GVAG
IDXX icon

Great Valley Advisor Group’s Idexx Laboratories IDXX Stock Holding History

Great Valley Advisor Group’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$312K Buy
594
+14
+2% +$7.85K ﹤0.01% 841
2026
Q1 		$326K Sell
580
-19
-3% -$12.2K 0.01% 798
2025
Q4 		$405K Buy
599
+99
+20% +$67.4K 0.01% 689
2025
Q3 		$319K Buy
500
+10
+2% +$6.07K 0.01% 752
2025
Q2 		$263K Hold
490
– – 0.01% 780
2025
Q1 		$205K Sell
490
-10
-2% -$4.34K ﹤0.01% 830
2024
Q4 		$207K Buy
500
+10
+2% +$4.39K ﹤0.01% 811
2024
Q3 		$248K Hold
490
– – 0.01% 743
2024
Q2 		$238K Buy
+490
New +$246K 0.01% 702
2023
Q3 		– Sell
-627
Closed -$315K – 705
2023
Q2 		$315K Sell
627
-68
-10% -$32.6K 0.01% 548
2023
Q1 		$348K Sell
695
-34
-5% -$16.3K 0.02% 505
2022
Q4 		$298K Sell
729
-22
-3% -$8.54K 0.02% 544
2022
Q3 		$245K Sell
751
-405
-35% -$149K 0.01% 587
2022
Q2 		$405K Buy
+1,156
New +$471K 0.02% 482

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Great Valley Advisor Group's IDXX Position: Q2 2026 in Review

Great Valley Advisor Group increased its Idexx Laboratories (IDXX) stake by 2.4% in Q2 2026, buying an estimated $7.85K and bringing the position to 594 shares worth $312K. The position accounts for ﹤0.01% of the portfolio, ranked #841.

Great Valley Advisor Group first reported a position in IDXX in Q2 2022 and has held it in 14 quarters since. The position peaked at $405K in Q2 2022. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Great Valley Advisor Group held 594 shares of Idexx Laboratories worth $312K as of Q2 2026.
  • Great Valley Advisor Group bought 14 Idexx Laboratories shares in Q2 2026, an estimated $7.85K.
  • Idexx Laboratories made up ﹤0.01% of Great Valley Advisor Group's portfolio in Q2 2026, its #841 holding.
  • Great Valley Advisor Group first reported a position in Idexx Laboratories in Q2 2022 and has held it in 14 quarters since.
  • Great Valley Advisor Group's Idexx Laboratories position peaked at $405K in Q2 2022.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Great Valley Advisor Group's 13F filing for Q2 2026, filed 10 Aug 2026.